Comparison of clinical and Spirometric response between nebulized salbutamol _ magnesium sulfate and nebulized salbutamol alone in acute asthma attack
Phase 3
Completed
- Conditions
- Acute attack asthma.Asthma
- Registration Number
- IRCT2015111015446N8
- Lead Sponsor
- Vice chanceller for research,Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 146
Inclusion Criteria
patients with clinical and para-clinical asthma has been confirmed; age 18 years and maximum 65 years.
Exclusion criteria: COPD; CHF; pneumonitis, pulmonary disease lightweight, pregnancy, lactation, is febrile, receiving salbutamol 6 hours before the visit.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical state. Timepoint: Before intervention,20,40,60,minutes after intervention. Method of measurement: Base on alert status,talking,wizing,use of respiratory mu.;Forced Expiratory Volum in First Secend (FEV1). Timepoint: Before intervention,20,40,60,minutes after intervention. Method of measurement: Mililiter with use of Peak Flow Meter.;Peak Expiratory Flow Rate(PEFR). Timepoint: Before intervention,20,40,60 minutes after intervention. Method of measurement: Mililiter with use of Peak Flow Meter.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: Before intervention,20,40,60 minutes after intervention. Method of measurement: mm Hg.;Pulse Rate. Timepoint: Before intervention,20,40,60 minutes after intervention. Method of measurement: Rate/Minutes.;Respiratory Rate. Timepoint: Before intervention,20,40,60 minutes after intervention. Method of measurement: Rate/Minutes.;Saturation of arterial blood oxygen (SO2 %). Timepoint: Before intervention,20,40,60 minutes after intervention. Method of measurement: with Pulse Oximetry.